BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Report Library

All Reports
Datamonitor Healthcare Oncology: Myelofibrosis Market Spotlight

Retail Price: $2,995.00

*BioMedTracker Subscriber Price: $2,095.00 - click here to log in

July 31, 2018

Myelofibrosis is a myeloproliferative neoplasm, which can exist as a primary disease known as primary myelofibrosis, or can evolve to post- polycythemia vera (PV) or post-essential thrombocythemia (ET) myelofibrosis from PV or ET. It is characterized by the buildup of scar tissue (fibrosis) in bone marrow, which leads to a reduction in blood cell production.

This Datamonitor Healthcare report contains a Market Spotlight module.

Disease Group Covered: Oncology
Back to the top Back to the top